Publisher
Springer International Publishing
Reference101 articles.
1. Adamson, S. J., & Sellman, J. D. (2003). A prototype screening instrument for cannabis use disorder: The Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Review, 22(3), 309–315. https://doi.org/10.1080/0959523031000154454
2. Alderks, C. E. (2013). Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003–2015 (update). In The CBHSQ Report (pp. 1–8). Rockville, MD, USA: Substance Abuse and Mental Health Services Administration (US).
3. American Psychological Association (APA). (2013). Diagnostic and Statistical Manual of Mental disorders (DSM-5). Washington, USA: American Psychiatric Association.
4. Araos, P., Vergara-Moragues, E., Pedraz, M., Pavón, F. J., Campos Cloute, R., Calado, M., … Rodríguez de Fonseca, F. (2014). Psychopathological comorbidity in cocaine users in outpatient treatment. Adicciones, 26(1), 15–26.
5. Baldacchino, A., Arvapalli, V., Oshun, A., & Tolomeo, S. (2015). Substance-induced mental disorders. In N. el-Guebaly, G. Carrà, & M. Galanter (Eds.), Textbook of addiction treatment: International perspectives. Milano, Italy: Springer. https://doi.org/10.1007/978-88-470-5322-9_88